Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
7680588680035
CH-58868
Konzentrat
Associated product:
ACTEMRA conc perf 400 mg/20 ml flac 20 ml
1 / 2
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.84 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 722.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2009
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 58868
- Drug name
- Actemra, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L04AC07
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 02/12/2008
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ACTEMRA conc perf 400 mg/20 ml flac 20 ml
- Description (DE)
- ACTEMRA Inf Konz 400 mg/20 ml Durchstf 20 ml
- Market launch
- 02/12/2008
- Narcotic (BTM)
- No